Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

61.42
Delayed Data
As of 4:00pm ET
 +0.45 / +0.74%
Today’s Change
39.24
Today|||52-Week Range
72.73
+47.18%
Year-to-Date
No recent news for Agios Pharmaceuticals Inc.

Today’s Trading

Previous close60.97
Today’s open60.85
Day’s range59.98 - 62.83
Volume304,691
Average volume (3 months)395,109
Market cap$3.0B
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-60.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+18.22%
P/E ratioNM
Price/Sales23.36
Price/Book7.18

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-4.01-2.40%
ICPTIntercept Pharmaceut...-0.34-0.55%
HCMHutchison China Medi...-2.72-8.03%
MDCOMedicines Co-0.21-0.80%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$1.60
Annual revenue (last year)$69.9M
Annual profit (last year)-$198.5M
Net profit margin-283.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts